Business modelOur Business
Platform technology development
and clinical development
In addition to developing platform technology for commercial use so that it can be applied to various kinds of drug discovery research, we are also pressing ahead with clinical research on the different types of diseases (blood cancers, genetic disorders, intractable blood diseases and other rare illnesses) for which this technology is expected to find application.
The value chain
We provide cell therapy products wherein cells are obtained from donors or patients at the hospital at the time of treatment, and cell expansion, processing or gene editing performed in accordance with the treatment needs, such as cell number expansion, gene editing, etc., in order to ensure high quality and safety.